Probable role of apelinergic system in occurrence of pulmonary diseases
https://doi.org/10.18093/0869-0189-2013-0-2-101-104
Abstract
Probable role of apelinergic system in occurrence of pulmonary diseases.
About the Authors
V. N. MineevRussian Federation
T. M. Lalaeva
Russian Federation
A. A. Kuzmina
Russian Federation
References
1. Минеев В.Н., Сорокина Л.Н., Берестовская В.С. и др. Содержание лептина в плазме крови при бронхиальной астме. Клин. мед. 2009; 7: 33–37.
2. Минеев В.Н., Лалаева Т.М., Васильева Т.С., Трофимов В.И. Фенотип бронхиальной астмы с ожирением. Пульмонология 2012; 2: 102–107.
3. Минеев В.Н., Лалаева Т.М., Трофимов В.И. Бронхиальная астма и ожирение: общие механизмы. Клин. мед. 2012; 89 (4): 4–10.
4. Минеев В.Н., Кузьмина А.А., Лалаева Т.М. Апелин – новый адипокин, много неясного. Совр. мед. наука 2012; 3: 142–157.
5. De Visser Y.P., Walther F.J., Laghmani E.H. et al. Apelin attenuates hyperoxic lung and heart injury in neonatal rats. Am. J. Respir. Crit. Care Med. 2010; 182: 1239–1250.
6. Piairo P., Moura R.S., Nogueira+Silva C. et al. The apelinergic system in the developing lung: expression and signaling. Peptides 2011; 32: 2474–2483.
7. Hosoya M., Kawamata Y., Fukusumi S. et al. Molecular and functional characteristics of APJ. Tissue distribution of mRNA and interaction with the endogenous ligand apelin. J. Biol. Chem. 2000; 275: 21061–21067.
8. Seyedabadi M., Goodchild A.K., Pilowsky P.M. Site-specific effects of apelin-13 in the rat medulla oblongata on arterial pressure and respiration. Auton. Neurosci. 2002; 101: 32–38.
9. Daviaud D., Boucher J., Gesta S. et al. TNF-α up-regulates apelin expression in human and mouse adipose tissue. FASEB J. 2006; 20: 1528–1530.
10. Leeper N.J., Tedesco M.M., Kojima Y. et al. Apelin prevents aortic aneurysm formation by inhibiting macrophage inflammation. Am. J. Physiol. Heart Circ. Physiol. 2009; 296: 1329–1335.
11. Gurzu B., Dumitriu I.L., Petrescu B.C. et al. Putative roles of apelin on airways hyperreactivity. Eur. Respir. J. 2007; 30 (Suppl. 51): 134s.
12. Eyries M., Siegfried G., Ciumas M. et al. Hypoxia-induced apelin expression regulates endothelial cell proliferation and regenerative angiogenesis. Circ. Res. 2008; 103: 432–440.
13. Geiger K., Muendlein A., Stark N. et al. Hypoxia induces apelin expression in human adipocytes. Horm. Metab. Res. 2011; 43: 380–385.
14. Henley D.E., Buchanan F., Gibson R. et al. Plasma apelin levels in obstructive sleep apnea and the effect of continuous positive airway pressure therapy. J. Endocrinol. 2009; 203: 181–188.
15. Chandra S.M., Razavi H., Kim J. et al. Disruption of the apelin-APJ system worsens hypoxia-induced pulmonary hypertension. Arterioscler. Thromb. Vasc. Biol. 2011; 31: 814–820.
16. Machura E., Ziora K., Ziora D. et al. Serum apelin-12 level is elevated in schoolchildren with atopic asthma. Respir. Med. 2013; 107: 196–201.
17. Machura E., Szczepanska M., Ziora K. et al. Evaluation of adipokines: apelin, visfatin, and resistin in children with atopic dermatitis. Mediators Inflamm. 2013; 2013:760691.
18. Reinehr T., Woelfle J., Roth C.L. Lack of association between apelin, insulin resistance, cardiovascular risk factors, and obesity in children: a longitudinal analysis. Metabolism 2011; 60: 1349–1354.
19. Biorntorp P. Endocrine abnormalities of obesity. Metabolism 1995; 44: 21–23.
20. Wei L., Hou X., Tatemoto K. Regulation of apelin mRNA expression by insulin and glucocorticoids in mouse 3T3-L1 adipocytes. Regul. Pept. 2005; 132: 27–32.
21. O'Carroll A.M., Don A.L., Lolait S.J. APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. J. Neuroendocrinol. 2003; 15: 1095–1101.
22. Adam F., Lopez J., Vatier C. et al. Antithrombotic effects of apelin: implication during metabolic disorders. Arterioscler. Thromb. Vasc. Biol. 2012; 32: A518.
Review
For citations:
Mineev V.N., Lalaeva T.M., Kuzmina A.A. Probable role of apelinergic system in occurrence of pulmonary diseases. PULMONOLOGIYA. 2013;(2):101-104. (In Russ.) https://doi.org/10.18093/0869-0189-2013-0-2-101-104